Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic


OTCPK:TRPXY - Post by User

Comment by Fundy13on Mar 28, 2019 1:43pm
99 Views
Post# 29549477

RE:RE:stopped out today

RE:RE:stopped out todayI knew financing was a good possibility and I knew the stock price woudl likely drop if that happened.  What has surprised me is how big a difference in financing this time compared to last.  They were just able to borrow at 5% with convertable debentures less then 6 months ago and now they are selling shares at $3.50 which is about a 20% discount to the 30 day moving average and attached warrants with a $3.50 exercise price.  I do not think I have even seen warrents issued below the existing share price before.  And all of this to by the company anouth 3-6 months of operations.  
I have not sold yet, but I am debating it.  This stock is going to have a hard time getting back over $3.50 without some really good news on the trials, or a buyout.  
I just do not get the short term band aid approach here.  Unless they know somethign we don't, which shoudl not be the case, if they have material information they should be sharing it with investors.
<< Previous
Bullboard Posts
Next >>